The Role of Amphiphilic Compounds in Nasal Nanoparticles

Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific researc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AAPS PharmSciTech 2024-11, Vol.25 (8), p.269, Article 269
Hauptverfasser: Quoc, Thinh To, Bíró, Krisztina, Pető, Ágota, Kósa, Dóra, Haimhoffer, Ádám, Lekli, István, Pallér, Ádám, Bak, István, Gyöngyösi, Alexandra, Fehér, Pálma, Bácskay, Ildikó, Ujhelyi, Zoltán
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 8
container_start_page 269
container_title AAPS PharmSciTech
container_volume 25
creator Quoc, Thinh To
Bíró, Krisztina
Pető, Ágota
Kósa, Dóra
Haimhoffer, Ádám
Lekli, István
Pallér, Ádám
Bak, István
Gyöngyösi, Alexandra
Fehér, Pálma
Bácskay, Ildikó
Ujhelyi, Zoltán
description Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results. Graphical Abstract
doi_str_mv 10.1208/s12249-024-03000-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3130826864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3130826864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-9fc1fa3dde278adfddea7cd93ac8479b8b8d28fc1b77f47bee5239f75342c5513</originalsourceid><addsrcrecordid>eNp9kEFLwzAUx4Mobk6_gAfp0Us0eWmX5DiGU2EoyDyHNE1cR9vUZD347Y12iichvDx4v_eH90PokpIbCkTcRgqQS0wgx4QRQrA4QlNaMIKlZHD8p5-gsxh3hACjkp2iCZPFHHICUyQ2W5u9-MZm3mWLtt_W6TW1yZa-7f3QVTGru-xJR92k2vleh31tGhvP0YnTTbQXh3-GXld3m-UDXj_fPy4Xa2yAwx5LZ6jTrKoscKErlxrNTSWZNiLnshSlqEAkqOTc5by0tgAmHS9YDqYoKJuh6zG3D_59sHGv2joa2zS6s36IilFGBMzFPE8ojKgJPsZgnepD3erwoShRX8bUaEwlY-rbmBJp6eqQP5StrX5XfhQlgI1ATKPuzQa180Po0s3_xX4CuyR2KA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130826864</pqid></control><display><type>article</type><title>The Role of Amphiphilic Compounds in Nasal Nanoparticles</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Quoc, Thinh To ; Bíró, Krisztina ; Pető, Ágota ; Kósa, Dóra ; Haimhoffer, Ádám ; Lekli, István ; Pallér, Ádám ; Bak, István ; Gyöngyösi, Alexandra ; Fehér, Pálma ; Bácskay, Ildikó ; Ujhelyi, Zoltán</creator><creatorcontrib>Quoc, Thinh To ; Bíró, Krisztina ; Pető, Ágota ; Kósa, Dóra ; Haimhoffer, Ádám ; Lekli, István ; Pallér, Ádám ; Bak, István ; Gyöngyösi, Alexandra ; Fehér, Pálma ; Bácskay, Ildikó ; Ujhelyi, Zoltán</creatorcontrib><description>Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results. Graphical Abstract</description><identifier>ISSN: 1530-9932</identifier><identifier>EISSN: 1530-9932</identifier><identifier>DOI: 10.1208/s12249-024-03000-8</identifier><identifier>PMID: 39562402</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Administration, Intranasal - methods ; Biochemistry ; Biological Availability ; Biomedical and Life Sciences ; Biomedicine ; Biotechnology ; Chemistry, Pharmaceutical - methods ; Drug Compounding - methods ; Drug Delivery Systems - methods ; Humans ; Nanoparticles - chemistry ; Nasal Mucosa - drug effects ; Nasal Mucosa - metabolism ; Particle Size ; Pharmacology/Toxicology ; Pharmacy ; Powders - chemistry ; Research Article ; Surface-Active Agents - chemistry</subject><ispartof>AAPS PharmSciTech, 2024-11, Vol.25 (8), p.269, Article 269</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c272t-9fc1fa3dde278adfddea7cd93ac8479b8b8d28fc1b77f47bee5239f75342c5513</cites><orcidid>0000-0001-9724-0614</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1208/s12249-024-03000-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1208/s12249-024-03000-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39562402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quoc, Thinh To</creatorcontrib><creatorcontrib>Bíró, Krisztina</creatorcontrib><creatorcontrib>Pető, Ágota</creatorcontrib><creatorcontrib>Kósa, Dóra</creatorcontrib><creatorcontrib>Haimhoffer, Ádám</creatorcontrib><creatorcontrib>Lekli, István</creatorcontrib><creatorcontrib>Pallér, Ádám</creatorcontrib><creatorcontrib>Bak, István</creatorcontrib><creatorcontrib>Gyöngyösi, Alexandra</creatorcontrib><creatorcontrib>Fehér, Pálma</creatorcontrib><creatorcontrib>Bácskay, Ildikó</creatorcontrib><creatorcontrib>Ujhelyi, Zoltán</creatorcontrib><title>The Role of Amphiphilic Compounds in Nasal Nanoparticles</title><title>AAPS PharmSciTech</title><addtitle>AAPS PharmSciTech</addtitle><addtitle>AAPS PharmSciTech</addtitle><description>Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results. Graphical Abstract</description><subject>Administration, Intranasal - methods</subject><subject>Biochemistry</subject><subject>Biological Availability</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Drug Compounding - methods</subject><subject>Drug Delivery Systems - methods</subject><subject>Humans</subject><subject>Nanoparticles - chemistry</subject><subject>Nasal Mucosa - drug effects</subject><subject>Nasal Mucosa - metabolism</subject><subject>Particle Size</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Powders - chemistry</subject><subject>Research Article</subject><subject>Surface-Active Agents - chemistry</subject><issn>1530-9932</issn><issn>1530-9932</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kEFLwzAUx4Mobk6_gAfp0Us0eWmX5DiGU2EoyDyHNE1cR9vUZD347Y12iichvDx4v_eH90PokpIbCkTcRgqQS0wgx4QRQrA4QlNaMIKlZHD8p5-gsxh3hACjkp2iCZPFHHICUyQ2W5u9-MZm3mWLtt_W6TW1yZa-7f3QVTGru-xJR92k2vleh31tGhvP0YnTTbQXh3-GXld3m-UDXj_fPy4Xa2yAwx5LZ6jTrKoscKErlxrNTSWZNiLnshSlqEAkqOTc5by0tgAmHS9YDqYoKJuh6zG3D_59sHGv2joa2zS6s36IilFGBMzFPE8ojKgJPsZgnepD3erwoShRX8bUaEwlY-rbmBJp6eqQP5StrX5XfhQlgI1ATKPuzQa180Po0s3_xX4CuyR2KA</recordid><startdate>20241119</startdate><enddate>20241119</enddate><creator>Quoc, Thinh To</creator><creator>Bíró, Krisztina</creator><creator>Pető, Ágota</creator><creator>Kósa, Dóra</creator><creator>Haimhoffer, Ádám</creator><creator>Lekli, István</creator><creator>Pallér, Ádám</creator><creator>Bak, István</creator><creator>Gyöngyösi, Alexandra</creator><creator>Fehér, Pálma</creator><creator>Bácskay, Ildikó</creator><creator>Ujhelyi, Zoltán</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9724-0614</orcidid></search><sort><creationdate>20241119</creationdate><title>The Role of Amphiphilic Compounds in Nasal Nanoparticles</title><author>Quoc, Thinh To ; Bíró, Krisztina ; Pető, Ágota ; Kósa, Dóra ; Haimhoffer, Ádám ; Lekli, István ; Pallér, Ádám ; Bak, István ; Gyöngyösi, Alexandra ; Fehér, Pálma ; Bácskay, Ildikó ; Ujhelyi, Zoltán</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-9fc1fa3dde278adfddea7cd93ac8479b8b8d28fc1b77f47bee5239f75342c5513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Administration, Intranasal - methods</topic><topic>Biochemistry</topic><topic>Biological Availability</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Drug Compounding - methods</topic><topic>Drug Delivery Systems - methods</topic><topic>Humans</topic><topic>Nanoparticles - chemistry</topic><topic>Nasal Mucosa - drug effects</topic><topic>Nasal Mucosa - metabolism</topic><topic>Particle Size</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Powders - chemistry</topic><topic>Research Article</topic><topic>Surface-Active Agents - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quoc, Thinh To</creatorcontrib><creatorcontrib>Bíró, Krisztina</creatorcontrib><creatorcontrib>Pető, Ágota</creatorcontrib><creatorcontrib>Kósa, Dóra</creatorcontrib><creatorcontrib>Haimhoffer, Ádám</creatorcontrib><creatorcontrib>Lekli, István</creatorcontrib><creatorcontrib>Pallér, Ádám</creatorcontrib><creatorcontrib>Bak, István</creatorcontrib><creatorcontrib>Gyöngyösi, Alexandra</creatorcontrib><creatorcontrib>Fehér, Pálma</creatorcontrib><creatorcontrib>Bácskay, Ildikó</creatorcontrib><creatorcontrib>Ujhelyi, Zoltán</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>AAPS PharmSciTech</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quoc, Thinh To</au><au>Bíró, Krisztina</au><au>Pető, Ágota</au><au>Kósa, Dóra</au><au>Haimhoffer, Ádám</au><au>Lekli, István</au><au>Pallér, Ádám</au><au>Bak, István</au><au>Gyöngyösi, Alexandra</au><au>Fehér, Pálma</au><au>Bácskay, Ildikó</au><au>Ujhelyi, Zoltán</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Amphiphilic Compounds in Nasal Nanoparticles</atitle><jtitle>AAPS PharmSciTech</jtitle><stitle>AAPS PharmSciTech</stitle><addtitle>AAPS PharmSciTech</addtitle><date>2024-11-19</date><risdate>2024</risdate><volume>25</volume><issue>8</issue><spage>269</spage><pages>269-</pages><artnum>269</artnum><issn>1530-9932</issn><eissn>1530-9932</eissn><abstract>Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results. Graphical Abstract</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39562402</pmid><doi>10.1208/s12249-024-03000-8</doi><orcidid>https://orcid.org/0000-0001-9724-0614</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1530-9932
ispartof AAPS PharmSciTech, 2024-11, Vol.25 (8), p.269, Article 269
issn 1530-9932
1530-9932
language eng
recordid cdi_proquest_miscellaneous_3130826864
source MEDLINE; SpringerNature Journals
subjects Administration, Intranasal - methods
Biochemistry
Biological Availability
Biomedical and Life Sciences
Biomedicine
Biotechnology
Chemistry, Pharmaceutical - methods
Drug Compounding - methods
Drug Delivery Systems - methods
Humans
Nanoparticles - chemistry
Nasal Mucosa - drug effects
Nasal Mucosa - metabolism
Particle Size
Pharmacology/Toxicology
Pharmacy
Powders - chemistry
Research Article
Surface-Active Agents - chemistry
title The Role of Amphiphilic Compounds in Nasal Nanoparticles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T13%3A13%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Amphiphilic%20Compounds%20in%20Nasal%20Nanoparticles&rft.jtitle=AAPS%20PharmSciTech&rft.au=Quoc,%20Thinh%20To&rft.date=2024-11-19&rft.volume=25&rft.issue=8&rft.spage=269&rft.pages=269-&rft.artnum=269&rft.issn=1530-9932&rft.eissn=1530-9932&rft_id=info:doi/10.1208/s12249-024-03000-8&rft_dat=%3Cproquest_cross%3E3130826864%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130826864&rft_id=info:pmid/39562402&rfr_iscdi=true